Dr. Singer joined the laboratory of Dr. Steven Smith in 2003 at City of Hope as a Research Fellow. She is developing nanoscale assemblies that specifically target cancer cells using the Bionanotechnology developed in Steve Smith’s City of Hope laboratory.
She is supported by a NRSA Post Doctoral Fellowship Award
from the National Cancer Institute.
Dr. Singer is a native of Indiana, where she received a Bachelor’s of Science in Biochemistry (with Honor’s) from Purdue University. She performed undergraduate research in Cynthia Stauffacher’s laboratory in the field of Structural Biology. She then worked for three years as a Research Associate at the Biotech company Amgen in Timothy Osslund’s laboratory in the Structural Biology Department, where she crystallized and helped solved the structures of human therapeutics including Epogen, Neupogen, and Kepivance. She then received her Ph.D. in Biochemistry from UCLA in a joint project from the laboratories of Dr. David Eisenberg and Dr. Dennis Slamon. She identified, isolated and characterized the binding regions of the HER3 receptor, which is overexpressed in Breast Cancer.